Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

Groundbreaking research unveils potential link between cytomegalovirus and Alzheimer's disease, offering new hope for ...

The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...

Cases of dementia in the U.S. are expected to steadily rise in the coming years, hitting 1 million annual cases by 2060.

When we think about dementia, we often think of a person experiencing memory loss and confusion. While it’s true that these ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease ...

Potential New Therapeutic Targets for Huntington's Disease Jan. 8 ... First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step Closer Dec. 19, 2024 — Phase I clinical ...

Research reveals how herpes simplex virus-1 may contribute to Alzheimer’s disease, offering new insights into the disease’s ...

While the Alzheimer’s market is projected to experience strong growth throughout the forecast period across the 8MM, unmet ...

Gum disease appears to disrupt brain activity, potentially increasing a person’s risk of cognitive decline.People with ...